Triple
T6003399
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Zepbound |
E133648
|
entity |
| Predicate | sharesActiveIngredientWith |
P40775
|
FINISHED |
| Object | Mounjaro |
E135131
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Mounjaro | Statement: [Zepbound, sharesActiveIngredientWith, Mounjaro]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Mounjaro Context triple: [Zepbound, sharesActiveIngredientWith, Mounjaro]
-
A.
Mounjaro
chosen
Mounjaro is a prescription medication (tirzepatide) used primarily to improve blood sugar control in adults with type 2 diabetes and increasingly known for its weight-loss effects.
-
B.
Trulicity
Trulicity is a prescription GLP-1 receptor agonist medication used to improve blood sugar control in adults with type 2 diabetes.
-
C.
Farxiga
Farxiga is a prescription SGLT2 inhibitor medication used primarily to treat type 2 diabetes and reduce the risk of cardiovascular and kidney complications.
-
D.
Januvia
Januvia is a prescription medication (sitagliptin) used to help control blood sugar levels in adults with type 2 diabetes.
-
E.
Vitrakvi
Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: sharesActiveIngredientWith Context triple: [Zepbound, sharesActiveIngredientWith, Mounjaro]
-
A.
sharesElementsWith
chosen
Indicates that two entities have one or more elements or components in common.
-
B.
sharesUniverseWith
Indicates that two entities exist within the same fictional or narrative universe, implying shared continuity, setting, or canon.
-
C.
sharesComponentsWith
Indicates that two entities have one or more structural or functional components in common.
-
D.
sharesInformationWith
Indicates that one entity communicates or provides information to another entity.
-
E.
sharesNameWith
Indicates that two entities have the same name or an identical naming designation.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00872444c8190bfaf1739dcec765c |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c04f0f63148190826198281dce3713 |
completed | March 22, 2026, 8:20 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c11365741c819097a43a49dd2428c1 |
completed | March 23, 2026, 10:18 a.m. |
| PD | Predicate disambiguation | batch_69c049e3316c819087ea635fa7ee8472 |
completed | March 22, 2026, 7:58 p.m. |
Created at: March 22, 2026, 4:06 p.m.